MedTrace Logo

Study of Risk Factors for Intraductal Papillary Mucinous Neoplasms Degeneration at the Nancy CHRU (IPMN)

NCT04901364 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2021-05-25

No results posted yet for this study

Summary

Cystic lesions of the pancreas are frequent with a risk of degeneration into adenocarcinoma with pejorative prognosis.

IPMNs require characterization to clarify their potential for degeneration. Clinical and morphological risk factors for degeneration determine the monitoring rate and the indication for pancreatic surgery.

Pancreatic surgery remains invasive with high morbidity and mortality rates.

Conditions

  • Study of Risk Factors for IPMNs Degeneration at the Nancy CHRU

Interventions

BEHAVIORAL

Sensitivity and specificity of risk factors for degeneration of IPMNs

Measurement of high-grade dysplasia or invasive cancer on the histological analysis of the surgical specimen

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Jean Baptiste JC CHEVAUX · Centre Hospitalier Regional Universitaire de Nancy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-10
Primary Completion
2021-09-30
Completion
2021-10-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04901364 on ClinicalTrials.gov